Patent · US Active

Rho kinase inhibitors and compositions and methods of use thereof

US12428413B2 · kind B2 · utility

0Cited by
0References
19Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 26, 2020
Grant dateSep 30, 2025
Priority date
Expiry dateDec 23, 2042

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07B2200/05
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Provided herein are certain inhibitors of ROCK (rho-kinases or rho-associated kinases), which are useful as medicament, for the treatment Huntington's disease in particular.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.